Wang Y, Yi P
World J Clin Cases. 2024; 12(19):3908-3917.
PMID: 38994286
PMC: 11235432.
DOI: 10.12998/wjcc.v12.i19.3908.
Toro G, Braile A, Liguori S, Moretti A, Landi G, Cecere A
Ther Adv Musculoskelet Dis. 2023; 15:1759720X231212747.
PMID: 38035253
PMC: 10685792.
DOI: 10.1177/1759720X231212747.
Li J, Cao H, Zhou X, Guo J, Zheng C
Front Pharmacol. 2023; 14:1235854.
PMID: 38027015
PMC: 10646494.
DOI: 10.3389/fphar.2023.1235854.
Gehrke B, Alves Coelho M, Brasil dAlva C, Madeira M
Arch Endocrinol Metab. 2023; 68:e220334.
PMID: 37948565
PMC: 10916794.
DOI: 10.20945/2359-4292-2022-0334.
Lo J, Yang W, Park-Sigal J, Ott S
Curr Osteoporos Rep. 2023; 21(5):592-608.
PMID: 37542683
PMC: 10858302.
DOI: 10.1007/s11914-023-00805-7.
The Dietary and Non-Dietary Management of Osteoporosis in Adult-Onset Celiac Disease: Current Status and Practical Guidance.
Al-Toma A, Herman A, Lems W, Mulder C
Nutrients. 2022; 14(21).
PMID: 36364816
PMC: 9654202.
DOI: 10.3390/nu14214554.
Controversies in Osteoporosis Treatment of Nursing Home Residents.
Niznik J, Gilliam M, Colon-Emeric C, Thorpe C, Lund J, Berry S
J Am Med Dir Assoc. 2022; 23(12):1928-1934.
PMID: 36335990
PMC: 9885478.
DOI: 10.1016/j.jamda.2022.09.013.
Plate osteosynthesis for atypical femoral fractures in patients with severely bowed femurs: comparing short versus long segment fixation - a case series.
Kwan Y, Shuy Y, Shi C, Ng A
Int J Burns Trauma. 2022; 12(3):73-82.
PMID: 35891970
PMC: 9301159.
Epimedin C Alleviates Glucocorticoid-Induced Suppression of Osteogenic Differentiation by Modulating PI3K/AKT/RUNX2 Signaling Pathway.
Xu Y, Chen S, Huang L, Han W, Shao Y, Chen M
Front Pharmacol. 2022; 13:894832.
PMID: 35860032
PMC: 9291512.
DOI: 10.3389/fphar.2022.894832.
Suppression of bone remodeling associated with long-term bisphosphonate treatment is mediated by microRNA-30a-5p.
Li X, Xu R, Ye J, Yuan F
Bioengineered. 2022; 13(4):9741-9753.
PMID: 35412438
PMC: 9161941.
DOI: 10.1080/21655979.2022.2060584.
Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China.
You R, Liu J, Ke L, Wan M, Zhang Y, Yu G
Front Pharmacol. 2022; 13:816248.
PMID: 35370751
PMC: 8971554.
DOI: 10.3389/fphar.2022.816248.
Pharmacologic Interventions for Fracture Risk Reduction in the Oldest Old: What Is the Evidence?.
Sfeir J, Pignolo R
JBMR Plus. 2021; 5(10):e10538.
PMID: 34693190
PMC: 8520064.
DOI: 10.1002/jbm4.10538.
Bone-targeted pH-responsive cerium nanoparticles for anabolic therapy in osteoporosis.
Dou C, Li J, He J, Luo F, Yu T, Dai Q
Bioact Mater. 2021; 6(12):4697-4706.
PMID: 34095626
PMC: 8164008.
DOI: 10.1016/j.bioactmat.2021.04.038.
Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years.
Lo J, Neugebauer R, Ettinger B, Chandra M, Hui R, Ott S
BMC Musculoskelet Disord. 2020; 21(1):801.
PMID: 33272248
PMC: 7713036.
DOI: 10.1186/s12891-020-03672-w.
Duration of Bisphosphonate Drug Holidays and Associated Fracture Risk.
Curtis J, Saag K, Arora T, Wright N, Yun H, Daigle S
Med Care. 2020; 58(5):419-426.
PMID: 31985584
PMC: 8287838.
DOI: 10.1097/MLR.0000000000001294.
Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.
van de Laarschot D, McKenna M, Abrahamsen B, Langdahl B, Cohen-Solal M, Guanabens N
J Clin Endocrinol Metab. 2019; 105(5).
PMID: 31867670
PMC: 7121199.
DOI: 10.1210/clinem/dgz295.
Atypical femoral fracture in the setting of alendronate treatment for osteoporosis: a case report and literature review.
Van Baarsel E, Patel V, Kesbeh Y, Kahf H, Alonzo N
J Community Hosp Intern Med Perspect. 2019; 9(4):340-343.
PMID: 31528285
PMC: 6735290.
DOI: 10.1080/20009666.2019.1644894.
High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan.
Sato H, Kondo N, Wakamatsu A, Kobayashi D, Nakatsue T, Wada Y
Rheumatol Int. 2019; 39(10):1803-1810.
PMID: 31385078
DOI: 10.1007/s00296-019-04407-4.
Value of pre-operative CTX serum levels in the prediction of medication-related osteonecrosis of the jaw (MRONJ): a retrospective clinical study.
Salgueiro M, Stribos M, Zhang L, Stevens M, Awad M, Elsalanty M
EPMA J. 2019; 10(1):21-29.
PMID: 30984311
PMC: 6459452.
DOI: 10.1007/s13167-019-0160-3.
Radiological criteria for atypical features of femur fractures: what we can learn when applied in a clinical study setting.
LeBlanc E, Rosales A, Genant H, Dell R, Friess D, Boardman D
Osteoporos Int. 2019; 30(6):1287-1295.
PMID: 30809724
DOI: 10.1007/s00198-019-04869-z.
